JP6892274B2 - ウイルス不活性化組成物 - Google Patents
ウイルス不活性化組成物 Download PDFInfo
- Publication number
- JP6892274B2 JP6892274B2 JP2017019272A JP2017019272A JP6892274B2 JP 6892274 B2 JP6892274 B2 JP 6892274B2 JP 2017019272 A JP2017019272 A JP 2017019272A JP 2017019272 A JP2017019272 A JP 2017019272A JP 6892274 B2 JP6892274 B2 JP 6892274B2
- Authority
- JP
- Japan
- Prior art keywords
- virus
- mass
- inactivating
- decylpyridinium
- bis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000700605 Viruses Species 0.000 title claims description 100
- 230000000415 inactivating effect Effects 0.000 title claims description 78
- 239000000203 mixture Substances 0.000 title claims description 56
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 48
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 44
- FGDLGJWCMASAHH-UHFFFAOYSA-N butane;dihydrobromide Chemical compound Br.Br.CCCC FGDLGJWCMASAHH-UHFFFAOYSA-N 0.000 claims description 42
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 40
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 22
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 22
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 20
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 17
- 244000309711 non-enveloped viruses Species 0.000 claims description 17
- 239000003623 enhancer Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 7
- 230000002779 inactivation Effects 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003245 coal Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 238000002156 mixing Methods 0.000 description 14
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 11
- 241001263478 Norovirus Species 0.000 description 11
- -1 β-aminoalkanol Chemical compound 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- 229960000686 benzalkonium chloride Drugs 0.000 description 7
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000003093 cationic surfactant Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000714201 Feline calicivirus Species 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000714198 Caliciviridae Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- JGFDZZLUDWMUQH-UHFFFAOYSA-N Didecyldimethylammonium Chemical compound CCCCCCCCCC[N+](C)(C)CCCCCCCCCC JGFDZZLUDWMUQH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 229940078672 didecyldimethylammonium Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Description
1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイド(ハイジェニアS−100、タマ化学工業社製)、炭酸水素ナトリウム、炭酸ナトリウム(いずれも和光純薬工業社製)、モノエタノールアミン(日本触媒社製)を表1に示す配合割合(質量%)で配合し、イオン交換水を加えて100質量%として試験液(本発明1〜9)を得た。
(試験ウイルス液の調製)
MEM培地(ナカライテスク社製)に牛胎仔血清を10%加えた細胞増殖培地を用いてCRFK細胞(JRBC細胞バンク)を組織培養シャーレ内に単層培養した。単層培養シャーレ内から細胞増殖培地を除去し、ネコカリシウイルス(Feline calicivirus F-9 ATCC VR-782)を接種した。次に、MEM培地に牛胎仔血清を2%加えた細胞維持培地を加えて37±1℃の炭酸ガスインキュベーター(CO2濃度5%)内で1〜5日間培養した。ネコカリシウイルスはノンエンベロープウイルスの一種であり、細胞培養できないノロウイルスの代替ウイルスとして広く使用されている。
細胞増殖培地を用い、使用細胞を組織培養用マイクロプレート(96穴)内で単層培養した後、細胞増殖培地を除去して細胞維持培地を0.1mLずつ加えた。次に、作用液の10倍希釈系列0.1mLをそれぞれ4穴ずつに接種し、37±1℃の炭酸ガスインキュベーター(CO2濃度5%)内で4〜7日間培養した。培養後、倒立位相差顕微鏡を用いて細胞の形態変化(細胞変性効果)の有無を観察し、Reed−Muench法により50%細胞培養感染量(TCID50)を算出して作用液1mL当たりの感染価に換算し、対照とした精製水の感染価を用いてウイルス除去率を算出した。
Claims (6)
- ウイルス不活性化成分として1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドと、
前記ウイルス不活性化成分の効力増強剤として炭酸水素ナトリウムと、
を水に溶解させて成り、前記1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドの配合量が0.05質量%以上1.0質量%以下であり、
前記炭酸水素ナトリウムの配合量が0.001質量%以上1.0質量%以下であることを特徴とするウイルス不活性化組成物。 - 前記炭酸水素ナトリウムの配合量が0.005質量%以上1.0質量%以下であることを特徴とする請求項1に記載のウイルス不活性化組成物。
- ウイルス不活性化成分として1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドと、
前記ウイルス不活性化成分の効力増強剤として炭酸ナトリウムと、
を水に溶解させて成り、前記1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドの配合量が0.05質量%以上1.0質量%以下であり、
前記炭酸ナトリウムの配合量が0.0005質量%以上1.0質量%以下であることを特徴とするウイルス不活性化組成物。 - 前記炭酸ナトリウムの配合量が0.005質量%以上1.0質量%以下であることを特徴とする請求項3に記載のウイルス不活性化組成物。
- ウイルス不活性化成分として1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドと、
前記ウイルス不活性化成分の効力増強剤としてモノエタノールアミンと、
を水に溶解させて成り、前記1,4−ビス(3,3′−(1−デシルピリジニウム)メチルオキシ)ブタンジブロマイドの配合量が0.05質量%以上1.0質量%以下であり、
前記モノエタノールアミンの配合量が0.1質量%以上1.0質量%以下であることを特徴とするウイルス不活性化組成物。 - 請求項1乃至請求項5のいずれかに記載のウイルス不活性化組成物をノンエンベロープウイルスに対して接触させるノンエンベロープウイルスの不活性化方法。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017019272A JP6892274B2 (ja) | 2017-02-06 | 2017-02-06 | ウイルス不活性化組成物 |
JP2021088945A JP2021120417A (ja) | 2017-02-06 | 2021-05-27 | ウイルス不活性化組成物 |
JP2022100778A JP2022125090A (ja) | 2017-02-06 | 2022-06-23 | ウイルス不活性化組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017019272A JP6892274B2 (ja) | 2017-02-06 | 2017-02-06 | ウイルス不活性化組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021088945A Division JP2021120417A (ja) | 2017-02-06 | 2021-05-27 | ウイルス不活性化組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018127401A JP2018127401A (ja) | 2018-08-16 |
JP6892274B2 true JP6892274B2 (ja) | 2021-06-23 |
Family
ID=63173601
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017019272A Active JP6892274B2 (ja) | 2017-02-06 | 2017-02-06 | ウイルス不活性化組成物 |
JP2021088945A Pending JP2021120417A (ja) | 2017-02-06 | 2021-05-27 | ウイルス不活性化組成物 |
JP2022100778A Pending JP2022125090A (ja) | 2017-02-06 | 2022-06-23 | ウイルス不活性化組成物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021088945A Pending JP2021120417A (ja) | 2017-02-06 | 2021-05-27 | ウイルス不活性化組成物 |
JP2022100778A Pending JP2022125090A (ja) | 2017-02-06 | 2022-06-23 | ウイルス不活性化組成物 |
Country Status (1)
Country | Link |
---|---|
JP (3) | JP6892274B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6892274B2 (ja) * | 2017-02-06 | 2021-06-23 | 大日本除蟲菊株式会社 | ウイルス不活性化組成物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL372273A1 (en) * | 2002-01-18 | 2005-07-11 | Lonza Ag | Virucidal disinfectant |
JP2008189645A (ja) * | 2007-02-01 | 2008-08-21 | Saraya Kk | 親水性ウイルスの不活化に有効な組成物 |
JP5108334B2 (ja) * | 2007-03-05 | 2012-12-26 | タマ化学工業株式会社 | 抗ウイルス剤 |
WO2009084211A1 (ja) * | 2007-12-27 | 2009-07-09 | Johnsondiversey Co., Ltd. | 殺菌消毒剤組成物およびこれを含有する殺菌消毒材、ならびにこれらを用いた殺菌消毒方法 |
JP5388325B2 (ja) * | 2008-06-02 | 2014-01-15 | フマキラー株式会社 | 抗ノロウイルス組成物 |
JP5255495B2 (ja) * | 2009-03-19 | 2013-08-07 | ディバーシー株式会社 | 殺カリシウイルス剤組成物およびその使用方法 |
JP5377098B2 (ja) * | 2009-06-12 | 2013-12-25 | 大日本除蟲菊株式会社 | ノロウイルス不活性化剤 |
JP5637525B2 (ja) * | 2010-04-28 | 2014-12-10 | 大日本除蟲菊株式会社 | 繊維製品の抗ウィルス処理方法 |
JP6239644B2 (ja) * | 2012-12-14 | 2017-11-29 | サバン ベンチャーズ ピーティーワイ リミテッド | 消毒剤 |
JP6286321B2 (ja) * | 2013-09-09 | 2018-02-28 | 吉田製薬株式会社 | 消毒剤 |
JP2015078479A (ja) * | 2013-09-10 | 2015-04-23 | ライオン株式会社 | 繊維製品のウイルス除去方法 |
JP6519080B2 (ja) * | 2015-06-22 | 2019-05-29 | ライオン株式会社 | 繊維製品用抗ウイルス組成物 |
JP2017007998A (ja) * | 2015-06-25 | 2017-01-12 | 株式会社Adeka | 除菌用シート |
JP2016210807A (ja) * | 2016-09-09 | 2016-12-15 | 株式会社ニイタカ | 消毒液及び消毒方法 |
JP6781006B2 (ja) * | 2016-10-05 | 2020-11-04 | 菱江化学株式会社 | 抗菌性液体洗浄剤、及び抗菌性洗浄剤用混合物の使用方法 |
JP6892274B2 (ja) * | 2017-02-06 | 2021-06-23 | 大日本除蟲菊株式会社 | ウイルス不活性化組成物 |
-
2017
- 2017-02-06 JP JP2017019272A patent/JP6892274B2/ja active Active
-
2021
- 2021-05-27 JP JP2021088945A patent/JP2021120417A/ja active Pending
-
2022
- 2022-06-23 JP JP2022100778A patent/JP2022125090A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021120417A (ja) | 2021-08-19 |
JP2018127401A (ja) | 2018-08-16 |
JP2022125090A (ja) | 2022-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2938638T3 (es) | Composición biocida para uso en un proceso de lavado de prendas de vestir | |
JP2010505964A (ja) | ウイルスを不活性化する方法 | |
JP2009173641A (ja) | 殺菌消毒剤組成物およびこれを含有する殺菌消毒材、ならびにこれらを用いた殺菌消毒方法 | |
Harada et al. | Inactivation of foot-and-mouth disease virus by commercially available disinfectants and cleaners | |
JP6704099B1 (ja) | 殺菌またはウイルス不活性化剤組成物、および殺菌またはウイルス不活性化効力増強方法 | |
WO2009093476A1 (ja) | 便座用除菌洗浄剤組成物およびこれを含有する除菌洗浄材、ならびにこれらを用いた除菌洗浄方法 | |
WO2013012007A1 (ja) | 抗ウイルス剤組成物 | |
JP5255495B2 (ja) | 殺カリシウイルス剤組成物およびその使用方法 | |
JP6783516B2 (ja) | カリシウイルス不活化効果を有する組成物 | |
JP2016113373A (ja) | 抗菌性、抗ウイルス性を有する水溶性組成物 | |
JP2022125090A (ja) | ウイルス不活性化組成物 | |
JP2019182853A (ja) | ウイルス不活性化剤、ノロウイルス不活性化剤及び衛生資材 | |
JP2019052107A (ja) | 殺菌・ウイルス不活化剤及び殺菌・ウイルス不活化方法 | |
JP2021046533A (ja) | 液体洗浄剤組成物 | |
TW202044992A (zh) | 殺菌或病毒不活性化劑組成物,及增強殺菌或病毒不活性化效力之方法 | |
GB2552261A (en) | Hygiene products | |
JP2021155368A (ja) | 殺菌・ウイルス不活性化組成物 | |
WO2022038955A1 (ja) | ウイルス不活性化剤組成物およびウイルス不活性化効力増強方法、並びにウイルス不活性化方法 | |
JP7340290B2 (ja) | 抗エンベロープウイルス中性洗浄剤、消毒剤組成物、及びエンベロープウイルスの不活性化方法 | |
JP2016117693A (ja) | 抗菌性、抗ウイルス性を有する水溶性組成物 | |
JP7220449B2 (ja) | 殺菌・ウイルス不活化剤及び殺菌・ウイルス不活化方法 | |
JP7378181B1 (ja) | 洗浄剤組成物 | |
JP7376903B2 (ja) | ウイルス不活性化剤及び衛生資材 | |
JP2021130634A (ja) | ヒトノロウイルス不活化剤 | |
WO2023145619A1 (ja) | 非エンベロープウイルス不活化組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200120 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201023 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201116 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210413 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210430 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210527 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6892274 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |